Filing Details
- Accession Number:
- 0000899243-19-025300
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-08 16:08:04
- Reporting Period:
- 2019-10-07
- Accepted Time:
- 2019-10-08 16:08:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Aravive Inc. | ARAV | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587788 | Jay Shepard | C/O Aravive, Inc., 3730 Kirby Drive, Suite 1200 Houston TX 77098 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-10-07 | 4,004 | $6.82 | 72,754 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units, which were previously reported in Table I following the date of grant.
Billionaire Hedge Funds
